fda ends semaglutide is on the shortage list US says two more doses of Novo Nordisk's weight-loss drug now available FDA semaglutide shortage, closing – FDA declares end to Wegovy

Ozempic is not suitable for individuals with type 1 diabetes, and pregnant patients or those planning to conceive should explore alternative weight management strategies

BPC 157, also known as body protection compound 157, has a precise molecular structure that defines its research utility

Nakamura Y, Mochida A, Choyke PL, Kobayashi H

These analgesic properties position DSIP as valuable research compound for developing non-opioid pain management strategies, understanding the relationship between sleep and pain processing, and investigating peptide-based approaches to chronic pain treatment

Rosiglitazone inhibited anaplastic TC cell proliferation in vitro and increased the effect of the chemotherapy paclitaxel (Copland et al.)